This compound is a pharmaceutical intermediate featuring a pyrrolidine ring with an amino group and a fluorine atom in specific stereochemical configuration. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1009075-48-2
TERT-BUTYL (3S,4R)-4-AMINO-3-FLUOROPIPERIDINE-1-CARBOXYLATE
Pharmaceutical intermediate
2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2-((2S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride
pharmaceutical intermediate
(S)-2-((1R,3aR,4S,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
pharmaceutical intermediate
Levofloxacin Q-Acid
Ofloxacin impurity reference standard
N-Phenyl-3-(trifluoromethyl)aniline
pharmaceutical intermediate
Tert-butyl (3S,4R)-3-amino-4-fluoropyrrolidine-1-carboxylate
Pharmaceutical intermediate
(3R,4R)-1-Boc-3-amino-4-fluoropyrrolidine
Pharmaceutical intermediate for drug synthesis
Tert-butyl (3S,4S)-3-amino-4-fluoropyrrolidine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
tert-butyl (3R,4S)-3-amino-4-fluoropyrrolidine-1-carboxylate
DXQXHFOCKKIWJL-NKWVEPMBSA-N
CC(C)(C)OC(=O)N1C[C@H]([C@H](C1)F)N
—